On 20 May 2026, Beauty Farm Medical and Health Industry Inc. executed an on-market share buyback of 22,000 ordinary shares, paying an aggregate HKD 0.43 million at prices ranging from HKD 19.56 to HKD 19.88 per share. The volume-weighted average purchase price stood at HKD 19.7461.

Following the repurchase, the company’s outstanding share count (excluding treasury shares) fell to 249.43 million, down from 249.45 million, representing a marginal 0.0088% reduction. Treasury shares increased to 2.16 million, while the total number of issued shares remained unchanged at 251.59 million.

The buyback forms part of the mandate approved on 27 June 2025, which authorises the repurchase of up to 23.58 million shares. Cumulative repurchases under this mandate have reached 2.16 million shares, equivalent to 0.92% of the share base at the time the mandate was granted (235.80 million shares).

Under Hong Kong Stock Exchange rules, Beauty Farm Medical is restricted from issuing new shares or selling treasury shares until 19 June 2026.